(1)
Gammazza, A. M.; Campanella, C.; Barone, R.; Caruso Bavisotto, C.; Gorska, M.; Wozniak, M.; Carini, F.; Cappello, F.; D’Anneo, A.; Lauricella, M.; Zummo, G.; Conway De Macario, E.; Macario, A. J.; Di Felice, V. Doxorubicin Anti-Tumor Mechanisms Include Hsp60 Post-Translational Modifications Leading to the Hsp60/P53 Complex Dissociation and Instauration of Replicative Senescence. Ital J Anat Embryol 2017, 121, 131.